CenterBook Partners LP Sells 7,088 Shares of Ventas, Inc. $VTR

CenterBook Partners LP cut its position in shares of Ventas, Inc. (NYSE:VTR) by 39.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,846 shares of the real estate investment trust’s stock after selling 7,088 shares during the quarter. CenterBook Partners LP’s holdings in Ventas were worth $759,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Cloud Capital Management LLC purchased a new position in shares of Ventas during the third quarter worth approximately $25,000. True Wealth Design LLC grew its holdings in shares of Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 405 shares during the last quarter. ORG Partners LLC raised its position in Ventas by 76.1% in the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 197 shares during the period. Wilmington Savings Fund Society FSB lifted its stake in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 180 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its position in Ventas by 52.7% during the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 185 shares during the period. Institutional investors own 94.18% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the transaction, the chief financial officer owned 138,434 shares in the company, valued at approximately $10,694,026.50. This represents a 17.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 86,106 shares of company stock valued at $6,931,397. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on VTR shares. KeyCorp lifted their price objective on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, February 9th. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Wells Fargo & Company raised their target price on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Citigroup lifted their target price on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $86.87.

Ventas Price Performance

Shares of NYSE VTR opened at $85.87 on Friday. The company has a 50 day simple moving average of $79.25 and a two-hundred day simple moving average of $74.50. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $87.24. The company has a market capitalization of $40.78 billion, a price-to-earnings ratio of 159.01, a P/E/G ratio of 2.10 and a beta of 0.77. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the business earned $0.81 EPS. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio (DPR) is 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.